Sandén, Emma
Khazaei, Somayeh
Tryggvadottir, Helga
Borgquist, Signe
Isaksson, Karolin
Jirström, Karin
Jernström, Helena
Funding for this research was provided by:
Cancerfonden (2017/368)
Medicinska Fakulteten, Lunds Universitet (NA)
Fru Berta Kamprads Stiftelse (2017-4)
Region Skåne (40620)
Skånes universitetssjukhus (NA)
Article History
Received: 15 November 2019
Revised: 13 January 2020
Accepted: 4 February 2020
First Online: 20 February 2020
Compliance with ethical standards
:
: HJ holds stocks in Pfizer. SB has received honoraria from Pfizer and Roche. KJ has received honoraria from Amgen, Astra Zeneca, Roche, and Bayer. All other authors declare that they have no conflict of interest.
: Written informed consents were collected from all patients and the study was approved by the ethics committee at Lund University (Dnr75-02, Dnr37-08, Dnr658-09, Dnr58-12, Dnr379-12, Dnr227-13, Dnr277-15 and Dnr458-15).